September 2024
Telix on $1b spending spree to build US radiopharmacy network
The biotech is investing heavily in global networks that will enable it to control the supply and distribution of nuclear medicines used to treat cancer.
July 2024
Telix shares hit new high on upgraded revenue forecast
The biotech’s shares double in value this year due to strong sales in the United States for its prostate cancer imaging product.
June 2024
AI beats the experts at detecting prostate cancer
When international AI teams competed with a pool of 62 radiologists in the first large-scale contest to diagnose prostate cancer, the machine won.
May 2024
The nine things every man needs to know about prostate cancer now
Experts at the cutting edge of new research into the causes and treatments answer the questions you might be afraid to ask.
April 2024
Revolutionary app offers vital prostate cancer info
A new online web app put out by the Prostate Cancer Foundation of Australia aims to help those living, recovering and at risk of the disease.
As prostate cancer surges, Australia breaks new ground
As low and middle-income countries await a surge in prostate cancer, Australia is driving ahead with cutting-edge treatments and new ways of solving old problems.
July 2023
Aussie team leads ‘life-saving’ prostate cancer breakthrough
Using novel technology, a new test aims to sharpen predictions about the aggressiveness of individual prostate cancers.
June 2023
‘Just missed out’: The AI start-up that went bust before the hype hit
Elliot Smith has watched with dismay as the artificial intelligence hype cycle reaches fever pitch, after his promising cancer screening start-up hit the skids.
July 2022
Why 6000 extra prostate cancers is not really an increase at all
While official figures make it seem like an extra 6000 men will be diagnosed with prostate cancer this year, it is not the case.
May 2022
Spare tyre increases risk death from prostate cancer
Men with a “spare tyre” of excess fat around the waist are at greater risk of dying from prostate cancer, researchers have found for the first time.
February 2022
One man’s mission to make prostate cancer fix open to all
Although the wealthy can pay for a new life-extending treatment for prostate cancer, funding is needed to make it accessible to all.
November 2021
Telix gets first regulatory tick on prostate cancer imaging product
The Therapeutic Goods Administration has approved the biotech’s product Illuccix, helping to push its shares higher by over 8 per cent.
October 2021
Taking the panic out of prostate cancer
While there is still a way to go, much of the emotive language has gone, the discourse has matured and momentum is building for new screening guidelines.
Prostate cancer screening guidelines ‘putting lives at risk’
Specialists say current guidelines don’t include new technology that can sharpen diagnosis and reduce the fear of overtreatment.
August 2021
Telix Pharma is on the cusp of first US FDA approval
The nuclear medicine company is not only going after the huge US market, it has the equivalent documentations with 17 other countries’ regulators.
January 2021
Coffee lowers risk of prostate cancer death, says new study
Every cup could reduce the chance by as much as 1 per cent, say researchers at China Medical University.
October 2020
Experts baffled by private v public prostate cancer treatments
Men with early prostate cancer have more radical treatment in the private health system, according to a Victorian study, but experts don't know why.
July 2020
The man who fell through every prostate cancer safety net
Position and education aside, like most Australian men, Tony Webber didn't have a clue that his symptoms might signal prostate cancer and the system didn't help him, writes Jill Margo.
June 2020
What caught Mike Milken's eye in Melbourne
'This work holds the key to eliminating prostate cancer as a cause of death,' says the American philanthropist.
March 2020
Prostate cancer's new standard of care
Australian researchers have provided the world with what is likely to become a new standard of care for men with prostate cancer.